secwatch.observer — SEC 8-K summary
======================================

Issuer:     BALCHEM CORP (BCPC)
CIK:        0000009326
Form:       8-K
Filed at:   2024-02-16T23:59:59+00:00
Accession:  0001628280-24-005203
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Balchem Q4 adj. EBITDA up 5.4% to $55.4M; free cash flow $56M, record Human Nutrition sales
--------------------------------------------------------------------------------

- Q4 GAAP EPS $0.82 vs $0.66 prior year; adjusted EPS $0.95 vs $0.94.
- Full year adjusted EBITDA $230.9M (+7.1%); record free cash flow $151.1M.
- Human Nutrition & Health Q4 sales $138M (+5.8%) record; earnings from ops up 43.8%.
- Dividend increased double-digit; $25.4M returned to shareholders in 2023.
- CEO expects both top and bottom line growth for full year 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/9326/000162828024005203/0001628280-24-005203-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/9326/000162828024005203/bcpc-20240216.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-005203

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer